Business Context and Reporting Period
This Form 8-K is a current report filed by Senti Biosciences Holdings, Inc. (SNTI) on August 14, 2026. The filing discloses the issuance of debt securities and provides updates regarding a potential merger transaction involving an entity affiliated with Celadon Partners.
Key Financial Metrics and Transactions
- Debt Issuance: On August 14, 2026, Senti Holdings, Inc. (a wholly owned subsidiary) issued and sold $4.0 million in aggregate principal amount of Senior Secured Convertible Notes to Celadon Partners SPV 24.
- Contingent Value Rights: A potential transaction exists where an entity affiliated with Celadon may merge with Senti Holdings. This could result in the issuance of contingent value rights to stockholders, potentially paying out up to $60.0 million in cash.
- Financial Statements: The filing text does not provide specific values for revenue, profit, cash flow, margins, or overall liquidity positions for the reporting period.
Material Changes and Agreements
The primary material change is the execution of the Senior Secured Convertible Notes under a Securities Purchase Agreement dated April 27, 2026. The terms of these Notes were previously detailed in 8-K filings from May 1, 2026, and May 26, 2026. Additionally, the company has filed a preliminary proxy statement on Schedule 14A (July 21, 2026) regarding the potential merger and contingent value rights.
Outlook, Risks, and Management Commentary
- Transaction Milestones: The potential $60.0 million cash payout is subject to the achievement of specific regulatory and sales milestones regarding the product candidate SENTI-202.
- Investor Action Required: Management urges investors to read the definitive proxy statement and other relevant documents before making voting decisions regarding the Subject Transactions.
- Participants: The Company, its directors, and executive officers are deemed participants in the solicitation of proxies for the Subject Transactions.
Key Facts for Investor Verification
- Verify the specific terms and conversion mechanics of the $4.0 million Senior Secured Convertible Notes issued to Celadon.
- Review the definitive proxy statement for details on the merger transaction and the specific regulatory/sales milestones required to trigger the $60.0 million contingent value right payout.
- Confirm the status of the product candidate SENTI-202 and its progress toward the milestones outlined in the Subject Transactions.
- Check for any amendments to the preliminary proxy statement filed on July 21, 2026.